✦ LIBER ✦

Treatment of acute leukaemia withm-AMSA in combination with cytosine arabinoside

✍ Scribed by H. S. Dhaliwal; M. S. Shannon; M. J. Barnett; H. G. Prentice; K. Bragman; J. S. Malpas; T. A. Lister

Publisher: Springer
Year: 1986
Tongue: English
Weight: 442 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00253066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of relapsed and refractory acu

Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

✍ Martin Gore; Ray Powles; Anil Lakhani; Sarah Milan; Jennifer Maitland; Glen Goss 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 425 KB

A total of 65 patients under the age of 55 with acute leukaemia received high-dose cytosine arabinoside (Ara-C) in combination with high-dose etoposide without an anthracycline. Complete remission rates for patients with relapsed or refractory acute myelogenous leukaemia (AML) were 15/25 (60%) and 1

Treatment of acute myeloid leukemia of a

Treatment of acute myeloid leukemia of adults with cytosine arabinoside in combination with 6-mercaptopurine

✍ John G. Buchanan; John R. D. Matthews; J. Graham Davison; Robert R. Grigor; Thom 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Remission of rheumatoid arthritis with t

Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA

✍ Ronenn Roubenoff; Richard J. Jones; Judith E. Karp; Mary Betty Stevens 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 1 views

A phase II study of high-dose cytosine a

A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults

✍ Michael J. Barnett; Ama Z. S. Rohatiner; Trivadi S. Ganesan; Michael A. Richards 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 325 KB

Combination chemotherapy with cytosine a

Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia

✍ E. Gluckman; A. Basch; B. Varet; B. Dreyfus 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 2 views

Thirty patients with acute granulocytic leukemia were treated with ARA-C (100 mg/m2 IV during 5 days) and RBD (100 mg/m\*/day during 3 days). Twentytwo patients with AML and eight with APML were treated. The drugs always induced severe pancytopenia lasting an average of 18 days. Sixteen patients ach

The treatment of poor prognosis myelomat

The treatment of poor prognosis myelomatosis with a cytosine arabinoside containing combination

✍ D. J. Dodwell; I. G. McGill 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

During the last 14 years a combination of cytosine arabinoside, vincristine, cyclophosphamide and prednisolone (ARA-COP) has been evaluated in 37 consecutive patients (M:F 25: 12) presenting with stage 3A (1 1) or stage 3B (26) multiple myeloma according to the staging system of Dune and Salmon (197